134 related articles for article (PubMed ID: 27914007)
41. Possible mechanism by which renal sympathetic denervation improves left ventricular remodelling after myocardial infarction.
Zheng XX; Li XY; Lyu YN; He YY; Wan WG; Zhu HL; Jiang XJ
Exp Physiol; 2016 Feb; 101(2):260-71. PubMed ID: 26556551
[TBL] [Abstract][Full Text] [Related]
42. Targeting of MMP2 activity in malignant tumors with a 68Ga-labeled gelatinase inhibitor cyclic peptide.
Liu Q; Pan D; Cheng C; Zhang A; Ma C; Wang L; Zhang D; Liu H; Jiang H; Wang T; Xu Y; Yang R; Chen F; Yang M; Zuo C
Nucl Med Biol; 2015 Dec; 42(12):939-44. PubMed ID: 26344861
[TBL] [Abstract][Full Text] [Related]
43. Selective targeting and timing of matrix metalloproteinase inhibition in post-myocardial infarction remodeling.
Yarbrough WM; Mukherjee R; Escobar GP; Mingoia JT; Sample JA; Hendrick JW; Dowdy KB; McLean JE; Lowry AS; O'Neill TP; Spinale FG
Circulation; 2003 Oct; 108(14):1753-9. PubMed ID: 12975256
[TBL] [Abstract][Full Text] [Related]
44. Quantitative assessment of myocardial blood flow and extracellular volume fraction using
Velasco C; Mota-Cobián A; Mota RA; Pellico J; Herranz F; Galán-Arriola C; Ibáñez B; Ruiz-Cabello J; Mateo J; España S
J Nucl Cardiol; 2020 Aug; 27(4):1249-1260. PubMed ID: 30927149
[TBL] [Abstract][Full Text] [Related]
45. ET(A)-receptor blockade prevents matrix metalloproteinase activation late postmyocardial infarction in the rat.
Podesser BK; Siwik DA; Eberli FR; Sam F; Ngoy S; Lambert J; Ngo K; Apstein CS; Colucci WS
Am J Physiol Heart Circ Physiol; 2001 Mar; 280(3):H984-91. PubMed ID: 11179039
[TBL] [Abstract][Full Text] [Related]
46. [Effects of angiotensin II receptor antagonism on matrix metalloproteinases and fibronectin in rats with experimental myocardial infarction].
Zhang X; Yang YJ; Zhu WL; Huang Y; Zhu ZM
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Nov; 34(11):1029-34. PubMed ID: 17288771
[TBL] [Abstract][Full Text] [Related]
47. TIMP2 deficiency accelerates adverse post-myocardial infarction remodeling because of enhanced MT1-MMP activity despite lack of MMP2 activation.
Kandalam V; Basu R; Abraham T; Wang X; Soloway PD; Jaworski DM; Oudit GY; Kassiri Z
Circ Res; 2010 Mar; 106(4):796-808. PubMed ID: 20056917
[TBL] [Abstract][Full Text] [Related]
48. Macrophage overexpression of matrix metalloproteinase-9 in aged mice improves diastolic physiology and cardiac wound healing after myocardial infarction.
Meschiari CA; Jung M; Iyer RP; Yabluchanskiy A; Toba H; Garrett MR; Lindsey ML
Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H224-H235. PubMed ID: 29030341
[TBL] [Abstract][Full Text] [Related]
49. Effect of angiotensin converting enzyme inhibition on myocardial phosphoinositide metabolism visualised with 1-[1-11C]-butyryl-2-palmitoyl-rac-glycerol in myocardial infarction in the rat.
Kagaya Y; Chida M; Imahori Y; Fujii R; Namiuchi S; Takeda M; Yamane Y; Otani H; Watanabe J; Fukuchi M; Tezuka F; Ido T; Shirato K
Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1516-22. PubMed ID: 12537008
[TBL] [Abstract][Full Text] [Related]
50. Controlled release of matrix metalloproteinase-1 plasmid DNA prevents left ventricular remodeling in chronic myocardial infarction of rats.
Lin X; Jo H; Ishii TM; Fujita M; Fu M; Tambara K; Yamamoto M; Tabata Y; Komeda M; Matsuoka S
Circ J; 2009 Dec; 73(12):2315-21. PubMed ID: 19797822
[TBL] [Abstract][Full Text] [Related]
51. Angiogenesis imaging in myocardial infarction using 68Ga-NOTA-RGD PET: characterization and application to therapeutic efficacy monitoring in rats.
Eo JS; Paeng JC; Lee S; Lee YS; Jeong JM; Kang KW; Chung JK; Lee DS
Coron Artery Dis; 2013 Jun; 24(4):303-11. PubMed ID: 23542160
[TBL] [Abstract][Full Text] [Related]
52. Trimetazidine suppresses oxidative stress, inhibits MMP-2 and MMP-9 expression, and prevents cardiac rupture in mice with myocardial infarction.
Gong W; Ma Y; Li A; Shi H; Nie S
Cardiovasc Ther; 2018 Oct; 36(5):e12460. PubMed ID: 30019466
[TBL] [Abstract][Full Text] [Related]
53. Imaging of Myocardial α
Nammas W; Paunonen C; Teuho J; Siekkinen R; Luoto P; Käkelä M; Hietanen A; Viljanen T; Dietz M; Prior JO; Li XG; Roivainen A; Knuuti J; Saraste A
J Nucl Med; 2024 Jan; 65(1):132-138. PubMed ID: 37973184
[TBL] [Abstract][Full Text] [Related]
54. Higher levels of collagen and facilitated healing protect against ventricular rupture following myocardial infarction.
Fang L; Gao XM; Samuel CS; Su Y; Lim YL; Dart AM; Du XJ
Clin Sci (Lond); 2008 Aug; 115(3):99-106. PubMed ID: 18248324
[TBL] [Abstract][Full Text] [Related]
55. Molecular imaging of early αvβ3 integrin expression predicts long-term left-ventricle remodeling after myocardial infarction in rats.
Sherif HM; Saraste A; Nekolla SG; Weidl E; Reder S; Tapfer A; Rudelius M; Higuchi T; Botnar RM; Wester HJ; Schwaiger M
J Nucl Med; 2012 Feb; 53(2):318-23. PubMed ID: 22302965
[TBL] [Abstract][Full Text] [Related]
56. Targeted imaging of the spatial and temporal variation of matrix metalloproteinase activity in a porcine model of postinfarct remodeling: relationship to myocardial dysfunction.
Sahul ZH; Mukherjee R; Song J; McAteer J; Stroud RE; Dione DP; Staib L; Papademetris X; Dobrucki LW; Duncan JS; Spinale FG; Sinusas AJ
Circ Cardiovasc Imaging; 2011 Jul; 4(4):381-91. PubMed ID: 21505092
[TBL] [Abstract][Full Text] [Related]
57. Atorvastatin reduces myocardial fibrosis in a rat model with post-myocardial infarction heart failure by increasing the matrix metalloproteinase-2/tissue matrix metalloproteinase inhibitor-2 ratio.
An Z; Yang G; He YQ; Dong N; Ge LL; Li SM; Zhang WQ
Chin Med J (Engl); 2013; 126(11):2149-56. PubMed ID: 23769575
[TBL] [Abstract][Full Text] [Related]
58. Biological characterization of F-18-labeled rhodamine B, a potential positron emission tomography perfusion tracer.
Bartholomä MD; He H; Pacak CA; Dunning P; Fahey FH; McGowan FX; Cowan DB; Treves ST; Packard AB
Nucl Med Biol; 2013 Nov; 40(8):1043-8. PubMed ID: 24011396
[TBL] [Abstract][Full Text] [Related]
59. Dual-tracer autoradiography with thallium-201 and iodine-125-metaiodobenzylguanidine in experimental myocardial infarction of rat.
Iwasaki T; Suzuki T; Tateno M; Sasaki Y; Oshima S; Imai S
J Nucl Med; 1996 Apr; 37(4):680-4. PubMed ID: 8691266
[TBL] [Abstract][Full Text] [Related]
60. Expression of the tissue inhibitor of metalloproteinase-3 by transplanted VSMCs modifies heart structure and function after myocardial infarction.
Jia ZB; Tian H; Kang K; Miao HZ; Liu KY; Jiang SL; Wang LP
Transpl Immunol; 2014 May; 30(4):149-58. PubMed ID: 24727088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
